相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Initial Characterization of Integrase-Defective Lentiviral Vectors for Pancreatic Cancer Gene Therapy
Naima Hanoun et al.
HUMAN GENE THERAPY (2016)
CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape
Zhen Wang et al.
CELL REPORTS (2016)
Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome
Eduard Ayuso
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
HIV-1 functional cure: will the dream come true?
Chao Liu et al.
BMC MEDICINE (2015)
The Integrase Cofactor LEDGF/p75 Associates with Iws1 and Spt6 for Postintegration Silencing of HIV-1 Gene Expression in Latently Infected Cells
Annabelle Gerard et al.
CELL HOST & MICROBE (2015)
Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases
Kentaro Ishida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Improved specificity of TALE-based genome editing using an expanded RVD repertoire
Jeffrey C. Miller et al.
NATURE METHODS (2015)
Broadening the versatility of lentiviral vectors as a tool in nucleic acid research via genetic code expansion
Yongxiang Zheng et al.
NUCLEIC ACIDS RESEARCH (2015)
mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5
Ulrike Mock et al.
NUCLEIC ACIDS RESEARCH (2015)
Damaging the Integrated HIV Proviral DNA with TALENs
Christy L. Strong et al.
PLOS ONE (2015)
Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
Blythe D. Sather et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Genome editing-based HIV therapies
Wan-Gang Gu
TRENDS IN BIOTECHNOLOGY (2015)
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
Gero Huetter et al.
VIRUSES-BASEL (2015)
Application of gene-editing technologies to HIV-1
Mary Jane Drake et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection
Panpan Hou et al.
SCIENTIFIC REPORTS (2015)
CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy
Kristina Allers et al.
CURRENT OPINION IN VIROLOGY (2015)
Targeted Modification of Gene Function Exploiting Homology-Directed Repair of TALEN-Mediated Double-Strand Breaks in Barley
Nagaveni Budhagatapalli et al.
G3-GENES GENOMES GENETICS (2015)
A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector
Hirotaka Ebina et al.
PLOS ONE (2015)
Efficient Design and Assembly of Custom TALENs Using the Golden Gate Platform
Tomas Cermak et al.
CHROMOSOMAL MUTAGENESIS, SECOND EDITION (2015)
Validation and Structural Characterization of the LEDGF/p75-MLL Interface as a New Target for the Treatment of MLL-Dependent Leukemia
Katerina Cermakova et al.
CANCER RESEARCH (2014)
Efficient delivery of lentiviral vectors into resting human CD4 T cells
X. Geng et al.
GENE THERAPY (2014)
TALEN Knockout of the PSIP1 Gene in Human Cells: Analyses of HIV-1 Replication and Allosteric Integrase Inhibitor Mechanism
Hind J. Fadel et al.
JOURNAL OF VIROLOGY (2014)
Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity
John P. Guilinger et al.
NATURE METHODS (2014)
Construction and characterization of adenoviral vectors for the delivery of TALENs into human cells
Maarten Holkers et al.
METHODS (2014)
Efficient strategies for TALEN-mediated genome editing in mammalian cell lines
Julien Valton et al.
METHODS (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation
Lambros Kordelas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage
Eli J. Fine et al.
NUCLEIC ACIDS RESEARCH (2014)
SAPTA: a new design tool for improving TALE nuclease activity
Yanni Lin et al.
NUCLEIC ACIDS RESEARCH (2014)
CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing
Tessa G. Montague et al.
NUCLEIC ACIDS RESEARCH (2014)
Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering
Jia Liu et al.
PLOS ONE (2014)
Bacterial Delivery of TALEN Proteins for Human Genome Editing
Jingyue Jia et al.
PLOS ONE (2014)
Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection
Lin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
F. Maldarelli et al.
SCIENCE (2014)
APOBEC3D and APOBEC3F Potently Promote HIV-1 Diversification and Evolution in Humanized Mouse Model
Kei Sato et al.
PLOS PATHOGENS (2014)
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Qiurong Ding et al.
CELL STEM CELL (2013)
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
David G. Ousterout et al.
MOLECULAR THERAPY (2013)
A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes
Jonathan L. Schmid-Burgk et al.
NATURE BIOTECHNOLOGY (2013)
A library of TAL effector nucleases spanning the human genome
Yongsub Kim et al.
NATURE BIOTECHNOLOGY (2013)
E-TALEN: a web tool to design TALENs for genome engineering
Florian Heigwer et al.
NUCLEIC ACIDS RESEARCH (2013)
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J. Cradick et al.
NUCLEIC ACIDS RESEARCH (2013)
A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly
Shijia Chen et al.
NUCLEIC ACIDS RESEARCH (2013)
High Efficiency In Vivo Genome Engineering with a Simplified 15-RVD GoldyTALEN Design
Alvin C. Ma et al.
PLOS ONE (2013)
Rapid Assembly of Customized TALENs into Multiple Delivery Systems
Zhengxing Zhang et al.
PLOS ONE (2013)
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Danit Finkelshtein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Newer Gene Editing Technologies toward HIV Gene Therapy
N. Manjunath et al.
VIRUSES-BASEL (2013)
Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity
Tetsushi Sakuma et al.
SCIENTIFIC REPORTS (2013)
Computational Predictions Provide Insights into the Biology of TAL Effector Target Sites
Jan Grau et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice
Ilona Hauber et al.
PLOS PATHOGENS (2013)
Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient
Steven A. Yukl et al.
PLOS PATHOGENS (2013)
Comparison of TALEN scaffolds in Xenopus tropicalis
Keisuke Nakajima et al.
BIOLOGY OPEN (2013)
Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization
Frauke Christ et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Overcoming Transcription Activator-like Effector (TALE) DNA Binding Domain Sensitivity to Cytosine Methylation
Julien Valton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
Joshua T. Schiffer et al.
JOURNAL OF VIROLOGY (2012)
Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease
Ning Sun et al.
MOLECULAR BIOSYSTEMS (2012)
In vivo genome editing using a high-efficiency TALEN system
Victoria M. Bedell et al.
NATURE (2012)
FLASH assembly of TALENs for high-throughput genome editing
Deepak Reyon et al.
NATURE BIOTECHNOLOGY (2012)
Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers
Sebastian Bultmann et al.
NUCLEIC ACIDS RESEARCH (2012)
TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction
Erin L. Doyle et al.
NUCLEIC ACIDS RESEARCH (2012)
The Crystal Structure of TAL Effector PthXo1 Bound to Its DNA Target
Amanda Nga-Sze Mak et al.
SCIENCE (2012)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Thuy Le et al.
AIDS (2011)
Zinc-Finger Nuclease Based Genome Surgery: It's All About Specificity
Eva-Maria Haendel et al.
CURRENT GENE THERAPY (2011)
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller et al.
NATURE BIOTECHNOLOGY (2011)
Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures
Yannick Doyon et al.
NATURE METHODS (2011)
TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain
Ting Li et al.
NUCLEIC ACIDS RESEARCH (2011)
Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting
Tomas Cermak et al.
NUCLEIC ACIDS RESEARCH (2011)
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
Claudio Mussolino et al.
NUCLEIC ACIDS RESEARCH (2011)
Humanized Rag1-/-γc-/- Mice Support Multilineage Hematopoiesis and Are Susceptible to HIV-1 Infection via Systemic and Vaginal Routes
Ramesh Akkina et al.
PLOS ONE (2011)
Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
Lina Josefsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks
Magdy M. Mahfouz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment
Bradford K. Berges et al.
RETROVIROLOGY (2011)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Tae-Wook Chun et al.
AIDS (2010)
TAL effectors: finding plant genes for disease and defense
Adam J. Bogdanove et al.
CURRENT OPINION IN PLANT BIOLOGY (2010)
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Michelle Christian et al.
GENETICS (2010)
Directed Evolution of an Enhanced and Highly Efficient FokI Cleavage Domain for Zinc Finger Nucleases
Jing Guo et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Evolution of the HIV-1 env Gene in the Rag2-/- γC-/- Humanized Mouse Model
William L. Ince et al.
JOURNAL OF VIROLOGY (2010)
Remarkable Lethal G-to-A Mutations in vif-Proficient HIV-1 Provirus by Individual APOBEC3 Proteins in Humanized Mice
Kei Sato et al.
JOURNAL OF VIROLOGY (2010)
HIV Sequence Variation Associated With env Antisense Adoptive T-cell Therapy in the hNSG Mouse Model
Rithun Mukherjee et al.
MOLECULAR THERAPY (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
Humanized Rag2-/-γc-/- (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year
Bradford K. Berges et al.
VIROLOGY (2010)
CCR5: From Natural Resistance to a New Anti-HIV Strategy
Lucia Lopalco
VIRUSES-BASEL (2010)
The CXCR4-Tropic Human Immunodeficiency Virus Envelope Promotes More-Efficient Gene Delivery to Resting CD4+ T Cells than the Vesicular Stomatitis Virus Glycoprotein G Envelope
Luis M. Agosto et al.
JOURNAL OF VIROLOGY (2009)
Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/-γc-/- Mouse
Shailesh K. Choudhary et al.
JOURNAL OF VIROLOGY (2009)
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Jens Boch et al.
SCIENCE (2009)
A Simple Cipher Governs DNA Recognition by TAL Effectors
Matthew J. Moscou et al.
SCIENCE (2009)
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Yogeshkumar Malam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag-/- γc-/- (RAG-hu) mice
Bradford K. Berges et al.
VIROLOGY (2008)
LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration
Ming-Chieh Shun et al.
GENES & DEVELOPMENT (2007)
Humanized mice in translational biomedical research
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2007)
HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/- (RAG-hu) mouse model
Bradford K. Berges et al.
RETROVIROLOGY (2006)
Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations
Heidi G. Sutherland et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Phenotyping of genetically engineered mice: Humane, ethical, environmental, and husbandry issues
MJ Brown et al.
ILAR JOURNAL (2006)
Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75
P Cherepanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy
MJ Li et al.
MOLECULAR THERAPY (2005)
Altering the tropism of lentiviral vectors through pseudotyping
J Cronin et al.
CURRENT GENE THERAPY (2005)
Gene transfer into human T lymphocytes and natural killer cells by Ad5/F35 chimeric adenoviral vectors
R Schroers et al.
EXPERIMENTAL HEMATOLOGY (2004)
Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrina
J McClure et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2000)
分享论文
